NephroGenex, Inc. develops novel drugs for the treatment of kidney disease. The Company is developing a small molecule drug that acts as an inhibitor of the pathogenic oxidative chemistries which are elevated in diabetic patients.
79 TW Alexander Drive
Building 4401, Suite290
Research Triangle Park, NC 27709-4188